18th Conference on Retroviruses
and Opportunistic Infections (CROI)
27 February–2 March 2011
"An EVA vaginal ring containing the NNRTI MIV-150 protects against SHIV-RT infection in vivo"
Rachel Singer, Nina Derby, Paul Mawson, Jeffrey Lifson, Michael Piatak Jr.,Jose Fernández-Romero, Thomas M. Zydowsky, Agegnehu Gettie, James Blanchard, Melissa Robbiani
Vaginal rings are a promising delivery vehicle for microbicides because they may improve adherence by eliminating the need for daily application and represent a coitally independent protection method. We previously evaluated the use of a silicone ring containing 50 mg of the NNRTI MIV-150 to prevent vaginal transmission of SHIV-RT in rhesus macaques challenged 2 weeks (2 wks) post-ring insertion (PRI). Although the silicone/MIV-150 ring reduced infection from 60 percent (3/5) in the control to 28.6 percent (2/7) in the test group, the difference was not statistically significant. Ethylene-vinyl acetate (EVA) rings have been shown to release MIV-150 better than silicone. In the current study, we formulated 40 percent EVA rings with 100 mg of MIV-150 and compared protection against SHIV-RT when macaques were challenged either 24 hours (24 h) or 2 wks PRI.
Depo-Provera–treated rhesus macaques (n=18) had either EVA/MIV-150 (n=7 each) or EVA/no drug (n=2 each) rings inserted vaginally before being challenged vaginally either 24 h or 2 wks PRI with 103 TCID50 SHIV-RT (SIVmac239 with HIV-1 RT). Infection was determined from plasma virus RNA and SIV-specific antibody (Ab) responses. MIV-150 levels in plasma at various time points were measured by radioimmunoassay. Statistical significance was determined with Fisher's exact test.
In the test groups, 1/7 animals challenged 24 h PRI and 1/7 animals challenged 2 wks PRI became infected (2/14 total, 14.3%). In the control groups, 2/2 animals challenged 24 h PRI and 1/2 animals challenged 2 wks PRI became infected (3/4 total, 75%). SIV RNA and SIV-specific Abs were detected in the plasma of all infected (but not uninfected) animals. These data indicate that EVA/MIV-150 rings provided significant protection (p<0.044) against vaginal SHIV-RT infection. MIV-150 was not detected in the plasma (lower limit of quantification = 2.7nM) 30 min to 72 h PRI.
EVA vaginal rings releasing MIV-150 blocked SHIV infection in macaques and warrant further development for the prevention of HIV infection. Future studies will determine the optimal dose of MIV-150 and timing of ring insertion relative to virus exposure.
Return to: Guide to Population Council activities
Offsite link: CROI Web site
firstname.lastname@example.org; +1 212 339 0509
Contacts and Resources
For 60 years, the Population Council has changed the way the world thinks about important health and development issues. Explore an interactive timeline of the Council's history, learn more about some of our key contributions, and watch a short video about why your support is so important to us.